Showing results (1-10 of 241) with videos related to

Sort By:
Pageof 25
Mineral and Electrolyte Metabolism|February 22, 2000
Modification of lipoproteins in uremia: oxidation, glycation and carbamoylationJ Galle, C Wanner
Kidney International. Supplement|December 1, 1995
Clinical utility of antilipidemic therapies in chronic renal allograft failureC Wanner, W Bartens, J Galle
Kidney International. Supplement|July 21, 1999
Atherogenic lipoproteins, oxidative stress, and cell deathJ Galle, K Heermeier, C Wanner
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Use of HMG-CoA Reductase Inhibitors after Kidney and Heart Transplantation: Lipid-Lowering and Immunosuppressive EffectsC Wanner, A Krämer-Guth, J Galle
Kidney International. Supplement|November 14, 1997
Inflammation, dyslipidemia and vascular risk factors in hemodialysis patientsC Wanner, J Zimmermann, T Quaschning, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|December 10, 1998
Impairment of endothelial function induced by glyc-oxidized lipoprotein a [Lp(a)]J Galle, B Winner, E Conzelmann, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1994
Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Effects of pressure and high-density lipoproteinJ Galle, M Ochslen, P Schollmeyer, et al.
Kidney International. Supplement|February 13, 2001
Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stressJ Galle, A Heinloth, C Wanner, et al.
Pageof 25